Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accuray Puts Emphasis On Hospitals As More Stable Revenue Source

This article was originally published in The Gray Sheet

Executive Summary

Accuray's strategy of ramping up sales efforts to hospital customers for its CyberKnife robotic radiosurgery system and taking the focus off freestanding radiology sites has aided the company during a challenging year, the firm said last week

You may also be interested in...



Accuray Seeks Broader Use Of CyberKnife As Credit Crunch Hurts Growth

Robotic radiosurgical system maker Accuray is continuing to collect data to support broader use of its CyberKnife system for cancer treatments even as it lowers 2008 revenue expectations citing a credit crunch for some U.S. purchasers

Ex-Janssen India Chief To Lead PE-Controlled Bharat Serums

Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.

Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.
UsernamePublicRestriction

Register

MT026478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel